Bath & Body Works, Inc. $BBWI Holdings Boosted by Entropy Technologies LP

Entropy Technologies LP raised its position in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 244.8% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 66,695 shares of the company’s stock after purchasing an additional 47,352 shares during the quarter. Entropy Technologies LP’s holdings in Bath & Body Works were worth $1,245,000 at the end of the most recent quarter.

A number of other hedge funds also recently modified their holdings of the business. Global Retirement Partners LLC acquired a new stake in shares of Bath & Body Works in the fourth quarter worth $31,000. Activest Wealth Management purchased a new stake in Bath & Body Works in the 4th quarter worth about $32,000. Geneos Wealth Management Inc. boosted its position in Bath & Body Works by 217.7% during the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock worth $35,000 after acquiring an additional 801 shares during the period. Parallel Advisors LLC boosted its position in Bath & Body Works by 42.6% during the 4th quarter. Parallel Advisors LLC now owns 1,897 shares of the company’s stock worth $38,000 after acquiring an additional 567 shares during the period. Finally, Danske Bank A S purchased a new position in Bath & Body Works during the 3rd quarter valued at about $39,000. Hedge funds and other institutional investors own 95.14% of the company’s stock.

Bath & Body Works Price Performance

Shares of NYSE:BBWI opened at $20.47 on Tuesday. The business has a 50-day moving average of $19.90 and a two-hundred day moving average of $20.43. Bath & Body Works, Inc. has a fifty-two week low of $14.27 and a fifty-two week high of $32.32. The stock has a market capitalization of $4.13 billion, a P/E ratio of 5.75, a P/E/G ratio of 1.97 and a beta of 1.38.

Bath & Body Works (NYSE:BBWI) last announced its quarterly earnings results on Wednesday, May 27th. The company reported $0.32 EPS for the quarter, beating the consensus estimate of $0.29 by $0.03. The company had revenue of $1.38 billion for the quarter, compared to the consensus estimate of $1.36 billion. Bath & Body Works had a negative return on equity of 45.34% and a net margin of 10.03%.The company’s revenue for the quarter was down 3.2% compared to the same quarter last year. During the same quarter last year, the company posted $0.49 earnings per share. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. As a group, research analysts expect that Bath & Body Works, Inc. will post 2.63 EPS for the current fiscal year.

Bath & Body Works Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, June 19th. Shareholders of record on Friday, June 5th were issued a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a yield of 3.9%. The ex-dividend date was Friday, June 5th. Bath & Body Works’s dividend payout ratio is 22.47%.

Analyst Ratings Changes

A number of brokerages have recently weighed in on BBWI. Morgan Stanley reiterated an “equal weight” rating and issued a $22.00 target price on shares of Bath & Body Works in a report on Monday, July 6th. TD Cowen raised their price target on shares of Bath & Body Works from $20.00 to $25.00 and gave the stock a “buy” rating in a report on Thursday, May 28th. Barclays dropped their price objective on shares of Bath & Body Works from $25.00 to $23.00 and set an “equal weight” rating on the stock in a research note on Thursday, May 28th. Telsey Advisory Group decreased their target price on shares of Bath & Body Works from $25.00 to $22.00 and set a “market perform” rating for the company in a research note on Thursday, May 28th. Finally, UBS Group dropped their price target on shares of Bath & Body Works from $22.00 to $19.00 and set a “neutral” rating on the stock in a research note on Wednesday, May 20th. Three analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, Bath & Body Works currently has an average rating of “Hold” and an average target price of $22.00.

Bath & Body Works Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.